Journal article
Generalised urticaria and angioedema complicating switch back from subcutaneous to intravenous vedolizumab therapy
- Abstract:
- We report a unique case of a 34-year-old man with ulcerative colitis, previously in complete remission with intravenous vedolizumab monotherapy, who developed an urticarial injection-site reaction on switching to a subcutaneous preparation and thereafter experienced a new hypersensitivity reaction on switch back to intravenous vedolizumab, necessitating complete discontinuation from this drug. This case highlights the need for vigilance on switching back to intravenous preparations of vedolizumab, in response to injection-site reactions with a subcutaneous preparation, even if the intravenous preparation had been previously well tolerated by the patient.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Publisher copy:
- 10.1136/flgastro-2023-102380
Authors
- Publisher:
- BMJ Publishing Group
- Journal:
- Frontline Gastroenterology More from this journal
- Volume:
- 14
- Issue:
- 5
- Pages:
- 432-434
- Place of publication:
- England
- Publication date:
- 2023-03-27
- Acceptance date:
- 2023-03-17
- DOI:
- EISSN:
-
2041-4145
- ISSN:
-
2041-4137
- Pmid:
-
37581188
- Language:
-
English
- Pubs id:
-
1541066
- UUID:
-
uuid_7fb11933-24bd-4fed-b993-aeb8a49ec275
- Local pid:
-
pubs:1541066
- Source identifiers:
-
W4361017980
- Deposit date:
-
2026-01-23
- ARK identifier:
Terms of use
- Copyright holder:
- Chauhan et al
- Copyright date:
- 2023
- Rights statement:
- © Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
- Licence:
- Other
If you are the owner of this record, you can report an update to it here: Report update to this record